Skip to main content
logo
Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.100
+0.020 (1.85%)
Aug 12, 2026, 3:34 PM EDT - Market open

Cocrystal Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
211321171663
Market Cap Growth
28.41%-34.34%17.44%10.20%-74.94%-33.87%
Enterprise Value
17.937.912.42-7.08-21.045.13
Last Close Price
1.100.982.021.721.957.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
94.17-----
PB Ratio
3.622.132.160.660.400.82
P/TBV Ratio
3.261.752.160.630.400.98

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
79.67-----
EV/EBITDA Ratio
---0.390.54-
EV/EBIT Ratio
---0.380.54-
EV/FCF Ratio
---0.480.98-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.260.180.160.060.000.00
Net Debt / Equity Ratio
-0.81-0.88-0.85-0.93-0.93-0.75
Net Debt / EBITDA Ratio
0.370.630.461.340.964.15
Net Debt / FCF Ratio
0.440.680.491.661.724.56
Asset Turnover
0.0300000
Quick Ratio
2.483.534.598.3731.2038.03
Current Ratio
2.663.684.778.9233.0438.40
Return on Equity (ROE)
-168.60%-111.40%-97.50%-54.54%-66.32%-21.81%
Return on Assets (ROA)
-105.43%-77.86%-79.96%-51.48%-64.59%-21.28%
Return on Invested Capital (ROIC)
-1191.82%-846.85%-1116.33%-833.36%-353.43%-72.25%
Return on Capital Employed (ROCE)
-142.28%-97.34%-91.62%-54.89%-66.11%-21.76%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-19.84%-10.97%-5.42%-18.52%-10.58%-60.04%
Total Shareholder Return
-19.84%-10.97%-5.42%-18.52%-10.58%-60.04%
SEC Filings: 10-K · 10-Q